๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Basal Cell Carcinoma Rebound After Cessation of Vismodegib in a Nevoid Basal Cell Carcinoma Syndrome Patient

โœ Scribed by Christopher M. Wolfe; W. Harris Green; Armand B. Cognetta Jr.; H. Keith Hatfield

Book ID
115305656
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
288 KB
Volume
38
Category
Article
ISSN
1076-0512

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Nevoid basal cell carcinoma syndrome in
Nevoid basal cell carcinoma syndrome in a black child
โœ Jenifer Hall; Kay A. Johnston; John P. McPhillips; Scott D. Barnes; Dirk M. Elst ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 46 KB
Molecular characterization of Italian ne
Molecular characterization of Italian nevoid basal cell carcinoma syndrome patients
โœ L. Pastorino; R. Cusano; S. Nasti; F. Faravelli; F. Forzano; C. Baldo; M. Barile ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 216 KB ๐Ÿ‘ 1 views

## Mutations in the PTCH gene, the human homolog of the Drosophila patched gene, have been found to lead to the autosomal dominant disorder termed Nevoid Basal Cell Carcinoma Syndrome (NBCCS, also called Gorlin Syndrome). Patients display an array of developmental anomalies and are prone to develop